Ablation of active spots in atrial fibrillation
Part of Heart & circulation clinical trials.
This trial is testing a new way to treat atrial fibrillation by using a catheter to target the specific areas in the heart that trigger the irregular heartbeat. If you have persistent atrial fibrillation and haven't had prior catheter ablation, you may be eligible to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have persistent atrial fibrillation (a type of irregular heartbeat) and your doctor has said you need a catheter ablation procedure.
- You have not had any prior catheter ablation or other ablation procedure for atrial fibrillation.
- You do not have moderate or severe heart valve disease, an artificial heart valve, or moderate-to-severe heart failure.
- You do not have active infections, bleeding disorders, severe kidney disease, or uncontrolled diabetes.
- You are able to give informed consent and, if female and able to have children, you agree to use effective birth control.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new approach to catheter ablation for people with persistent atrial fibrillation (a type of irregular heartbeat). It may be an option if you have not responded well to or could not tolerate a rhythm-control medication.
This trial tests if a repeat catheter ablation procedure can help people with persistent atrial fibrillation who still have symptoms after their first procedure. If you've already had a pulmonary vein isolation, this study may offer a chance at better rhythm control.
This trial tests a new catheter system to treat atrial fibrillation (AF) by creating small scars in the heart to block faulty signals. It may help people with symptoms that continue despite medication and who are scheduled for a standard ablation procedure.
This trial studies catheter ablation, a procedure that targets heart rhythm triggers, for people with atrial fibrillation (an irregular heartbeat). It may help improve rhythm control, but you must meet specific heart and testing requirements and avoid certain conditions.
This trial is studying a way to improve the entire process of catheter ablation for atrial fibrillation. It may help people who are having this procedure for the first time and have a normal-sized left atrium and good heart function.
This trial is testing a specific approach to catheter ablation for people with persistent atrial fibrillation. It aims to improve how abnormal heart tissue is targeted to help restore a normal rhythm.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.